Costa Rica vs Laos: Access to anti-retroviral drugs, male (%)
Costa Rica
61.0%
in 2024
Laos
61.0%
in 2024
Costa Rica rank
97th
Laos rank
97th
Access to anti-retroviral drugs, male (%) over time
- Costa Rica
- Laos
How they compare
Costa Rica currently reports 61.0% against 61.0% in Laos, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 97th and Laos ranks 97th of 141 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.6% | 5.8% | 10.8% | Costa Rica |
| 2010s | 40.8% | 25.4% | 15.4% | Costa Rica |
| 2020s | 59.2% | 51.4% | 7.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Costa Rica or Laos?
- Costa Rica, at 61.0% against 61.0% in Laos as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Costa Rica and Laos?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Laos?
- 24 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Laos rank globally for access to anti-retroviral drugs, male?
- Costa Rica ranks 97th and Laos ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.